1-6 of 6
Kevin Duffy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma

Clinical Trials & Observations
Claire Roddie, Lazaros J. Lekakis, Maria A. V. Marzolini, Aravind Ramakrishnan, Yiyun Zhang, Yanqing Hu, Vijay G. R. Peddareddigari, Nushmia Khokhar, Robert Chen, Silvia Basilico, Meera Raymond, Frederick Arce Vargas, Kevin Duffy, Wolfram Brugger, Maeve A. O’Reilly, Leigh Wood, David C. Linch, Karl S. Peggs, Carlos Bachier, Elizabeth Lihua Budde, Connie Lee Batlevi, Nancy Bartlett, David Irvine, Eleni Tholouli, Wendy Osborne, Kirit M. Ardeshna, Martin A. Pule
Journal: Blood
Blood (2023) 141 (20): 2470–2482.
https://doi.org/10.1182/blood.2022018598
Published: 2023
Includes: Supplemental data
Journal Articles

Industrialization of an Academic Miltenyi Prodigy-Based CAR T Process

Abigail Culshaw, Frederick Arce Vargas, Gerardo Santiago Toledo, Claire Roddie, Paul Shaughnessy, Virginie Cerec, Kevin Duffy, Serena Perna, Wolfram Brugger, Michael Merges, Martin Pule
Journal: Blood
Blood (2021) 138 (Supplement 1): 477.
https://doi.org/10.1182/blood-2021-153031
Published: 2021
Journal Articles

A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies

Clinical Trials & Observations
Harriet S. Walter, Simon A. Rule, Martin J. S. Dyer, Lionel Karlin, Ceri Jones, Bruno Cazin, Philippe Quittet, Nimish Shah, Claire V. Hutchinson, Hideyuki Honda, Kevin Duffy, Joseph Birkett, Virginia Jamieson, Nigel Courtenay-Luck, Toshio Yoshizawa, John Sharpe, Tomoya Ohno, Shinichiro Abe, Akihisa Nishimura, Guillaume Cartron, Franck Morschhauser, Christopher Fegan, Gilles Salles
Journal: Blood
Blood (2016) 127 (4): 411–419.
https://doi.org/10.1182/blood-2015-08-664086
Published: 2016
Includes: Supplemental data
Journal Articles

The Bruton’s Tyrosine Kinase (BTK) Inhibitor ONO-4059: Promising Single Agent Activity and Well Tolerated in Patients with High Risk Chronic Lymphocytic Leukaemia (CLL)

Christopher Fegan, Joanne Bagshawe, Gilles Salles, MDPhD, Lionel Karlin, Simon Rule, Nimish Shah, Franck Morschhauser, Louis Terriou, Martin JS Dyer, Harriet Walter, Claire Hutchinson, Guillaume Cartron, MD, John Sharpe, Kevin Duffy, Akhisa Nishimura, Shin-ichiro Abe, Hideyuki Honda, Tomoko Yasuhiro, Toshio Yoshizawa, Joseph Birkett, Nigel Courtenay-Luck
Journal: Blood
Blood (2014) 124 (21): 3328.
https://doi.org/10.1182/blood.V124.21.3328.3328
Published: 2014
Journal Articles

Species Specificity and Receptor Domain Interaction of a Small Molecule TPO Receptor Agonist.

Connie L. Erickson-Miller, PhD, Evelyn Delorme, PHD, Maya Iskander, Leslie Giampa, Christpher B. Hopson, Juan Luengo, PhD, Kevin Duffy, PhD, Susan B. Dillon, PhD, Jon Rosen, PhD, Stephen Miller, PhD, Peter Lamb, PhD, Shin-Shay Tian, PhD
Journal: Blood
Blood (2004) 104 (11): 2909.
https://doi.org/10.1182/blood.V104.11.2909.2909
Published: 2004
Journal Articles

Biological Activity and Selectivity for Tpo Receptor of the Orally Bioavailable, Small Molecule Tpo Receptor Agonist, SB-497115.

Connie Erickson-Miller, Evelyn Delorme, Leslie Giampa, Christopher Hopson, Elizabeth Valoret, Shin-Shay Tian, Stephen G. Miller, Richard Keenan, Jon Rosen, Susan Dillon, Kevin Duffy, Peter Lamb, Juan Luengo
Journal: Blood
Blood (2004) 104 (11): 2912.
https://doi.org/10.1182/blood.V104.11.2912.2912
Published: 2004